Our Firm is representing numerous clients who have GranuFlo and NaturaLyte lawsuits pending in the federal multidistrict litigation, and we are pleased to see this proceeding moving forward.
New York, New York (PRWEB) March 16, 2015
GranuFlo and NaturaLyte lawsuits (http://www.granuflolawsuit2014.com/) filed on behalf of individuals who allegedly suffered serious cardiovascular complications due to treatment with one of the two dialysis concentrates continue to move forward in the federal multidistrict litigation underway in U.S. District Court, District of Massachusetts, where Bernstein Liebhard LLP is currently representing numerous clients. Court records indicate that on March 11, 2015, the parties jointly submitted a Proposed Order intended to address certain issues raised by recent motions to dismiss. (In re Fresenius GranuFlo/Naturalyte Dialysate Litigation, MDL No. 2428)
“Our Firm is representing numerous clients who have GranuFlo and NaturaLyte lawsuits pending in the federal multidistrict litigation, and we are pleased to see this proceeding moving forward. This Proposed Order sets forth protocols that, if adopted by the Court, would allow certain cases to be dismissed without prejudice within a specified period of time so that the affected plaintiffs may select a new “home forum” designation,” says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to evaluate claims on behalf of individuals who were allegedly harmed by GranuFlo or NaturaLyte.
GranuFlo and NaturaLyte are acid concentrates manufactured by Fresenius Medical Care that are used to remove toxins from the blood of patients undergoing hemodialysis treatments. According to court documents, all of the claims pending in the federal multidistrict litigation were filed in the wake of the 2012 GranuFlo recall, which was announced by the U.S. Food & Drug Administration (FDA) after GranuFlo and NaturaLyte were linked to heart attacks, strokes and other serious cardiovascular events that occurred among patients administered one of the two concentrates during dialysis treatments. The recall was designated Class I by the FDA, which signifies that a medical product poses a risk of serious injury or death.
Court records indicate that more than 2,600 product liability lawsuits are now pending in District of Massachusetts, all of which accuse Fresenius Medical Care of failing to provide adequate warnings regarding the serious cardiovascular risks associated with GranuFlo and NaturaLyte. Plaintiffs further allege that Fresenius concealed its knowledge of these issues, and instead continued to aggressively market the dialysis products in order to protect profits derived from their sale.
Dialysis patients who allegedly suffered a serious cardiovascular event within 72 hours of the administration of GranuFlo or NaturaLyte may be entitled to pursue a case against Fresenius Medical Care. To learn more about filing a GranuFlo lawsuit, please visit Bernstein Liebhard LLP’s website, or the Firm’s Facebook page: https://www.facebook.com/granuflolawsuit. For additional information, and to arrange for a free case review, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP